Status:
COMPLETED
Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
Lead Sponsor:
Fovea Pharmaceuticals SA
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a phase 2 study that will consist of 3 visits during a 3 week period conducted at up to 5 sites. The purpose of this study is to determine how effective the combination of Pred Mild® and FOV11...
Eligibility Criteria
Inclusion
- history of ocular allergies and a positive skin test reaction to allergens within the past 24 months and a history of chronic eye irritation;
Exclusion
- active ocular infection; clinically significant blepharitis; follicular conjunctivitis; iritis; any type of glaucoma; ocular surgery within past 3 months; pregnancy or nursing
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT00833495
Start Date
January 1 2009
End Date
March 1 2009
Last Update
March 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ora
Andover, Massachusetts, United States, 01810